507476-70-2

Basic information

• Product Name: 5-broMoquinoline-8-carbonitrile
• Synonyms: 5-broMoquinoline-8-carbonitrile
• CAS NO: 507476-70-2
• Molecular Formula: C₁₀H₅BrN₂
• Molecular Weight: 233.0641
• Mol File: 507476-70-2.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 367.6±22.0 °C(Predicted)
• Appearance: /
• Density: 1.66±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 0.68±0.29(Predicted)
• CAS DataBase Reference: 5-broMoquinoline-8-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-broMoquinoline-8-carbonitrile(507476-70-2)
• EPA Substance Registry System: 5-broMoquinoline-8-carbonitrile(507476-70-2)

Safety Data

• Hazardous Substances Data: 507476-70-2(Hazardous Substances Data)

Usage

General Description

5-bromoquinoline-8-carbonitrile is a chemical compound with the molecular formula C10H5BrN2. It is a yellow to brown solid that is commonly used in the pharmaceutical industry for the synthesis of various bioactive compounds and pharmaceutical intermediates. 5-broMoquinoline-8-carbonitrile is often utilized as a building block in the production of potential drug candidates for the treatment of various diseases, including cancer and infectious diseases. Its unique molecular structure and versatile reactivity make it a valuable tool for the development of new drugs and therapeutic agents. Additionally, it is also used as a research chemical for the study of chemical reactions and organic synthesis processes.

Upstream product

• 573758-03-9 5-amino-quinoline-8-carbonitrile 
• 885267-41-4 5-bromoquinoline-8-carboaldehyde 
• 557-21-1 zinc(II) cyanide 

Downstream Products

• 1445782-00-2 5-(((3S,4R)-4-(3-(trifluoromethoxy)phenyl)pyrrolidin-3-yl)amino)quinoline-8-carboxamide 

Relevant articles and documents

NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF

The present invention relates to photoactivatable compounds and methods of use thereof for determining binding site and other structural information about RNA transcripts. The invention also provides methods of identifying RNA transcripts that bind compounds and are thus druggable, methods of screening drug candidates, and methods of determining drug binding sites and/or accessible or reactive sites on a target RNA.

POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as toll-like receptor 7/8 (TLR7/8) antagonists. In Formula (I), Ring A is aryl or heteroaryl; Ring B is aryl or heteroary; and X is C(R4)2, O, NR4, S, S(R4), or S(R4)2.

CCR6 COMPOUNDS

Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6. Pharmaceutical compositions of the compounds of formula (I) are also provided. Further provided in the present disclosure